Public Consultation: Draft 2022-23 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP
Page last updated: 17 June 2022
Consultation on the content of the draft 2022-23 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical Benefits Scheme and designated vaccines on the National Immunisation Program is now open.
This CRIS sets out the fees that will apply for the 2022-23 financial year and provides information on how the Department of Health (the Department) implements cost recovery for:
- Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for medicines seeking to be listed on the Pharmaceutical Benefits Scheme (PBS); or vaccines to be listed on the National Immunisation Program (NIP).
- Applicant-driven PBS listing and list management activities.
Fees for the 2022-23 financial year will commence on 1 August 2022.
The final CRIS will be published before the fee changes take effect.
Department of Health welcomes your feedback
Please provide your comments on the content of the draft 2022-23 CRIS via email: firstname.lastname@example.org. Consultation closes COB Thursday 30 June 2022.